Filing Details
- Accession Number:
- 0001104659-20-056066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-04 12:28:21
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-05-04 12:28:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1173281 | Neubase Therapeutics Inc. | NBSE | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579887 | Samuel Backenroth | C/O 700 Technology Drive, Third Floor Pittsburgh PA 15219 | Cfo, Treasurer & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-30 | 1,000 | $6.00 | 11,630 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The power of attorney under which this form was signed is on file with the Commission.